Luisa Ugedo - Nursing Science

Author Information

Luisa Ugedo is affiliated with the Department of Pharmacology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU) in Leioa, Spain. Her research primarily focuses on pharmacological studies, with a keen interest in understanding the neural mechanisms underpinning various neurological conditions.

Research Contributions

Luisa Ugedo has made significant contributions to the field of pharmacology, particularly in understanding the effects of neurotransmitter systems on neurological disorders. Her research has explored the impacts of dopaminergic denervation, serotonergic control, and cannabinoids on cortical and basal ganglia circuits. Ugedo has also delved into the effects of environmental enrichment on cognition and neural plasticity in models of schizophrenia and Parkinson's disease. Her work aims to uncover potential biomarkers and therapeutic targets for these conditions.

Aliases

L Ugedo, L. Ugedo, Luisa Ugedo

Publication and Citation Metrics

Metric	Value
Citation Count	2406
H-Index	28
Paper Count	124

Publications:

The effect of 5‐HT1A receptor agonists on the entopeduncular nucleus is modified in 6‐hydroxydopamine‐lesioned rats

DOI: 10.1111/bph.15437

Year: 2021

Dopaminergic denervation impairs cortical motor and associative/limbic information processing through the basal ganglia and its modulation by the CB1 receptor

DOI: 10.1016/j.nbd.2020.105214

Year: 2021

Serotonergic control of the glutamatergic neurons of the subthalamic nucleus.

DOI: 10.1016/bs.pbr.2020.11.003

Year: 2021

6‐Hydroxydopamine lesion and levodopa treatment modify the effect of buspirone in the substantia nigra pars reticulata

DOI: 10.1111/bph.15145

Year: 2020

Changes in day/night activity in the 6-OHDA-induced experimental model of Parkinson´s disease: Exploring prodromal biomarkers

DOI: 10.21203/rs.3.rs-50664/v1

Year: 2020

Changes in Day/Night Activity in the 6-OHDA-Induced Experimental Model of Parkinson’s Disease: Exploring Prodromal Biomarkers

DOI: 10.3389/fnins.2020.590029

Year: 2020

Changes in day/night activity in the 6-OHDA-induced experimental model of Parkinson´s disease: Exploring prodromal biomarkers

DOI: 10.21203/rs.3.rs-50664/v2

Year: 2020

Cannabinoids differentially modulate cortical information transmission through the sensorimotor or medial prefrontal basal ganglia circuits

DOI: 10.1111/bph.14613

Year: 2019

Acute L-DOPA administration reverses changes in firing pattern and low frequency oscillatory activity in the entopeduncular nucleus from long term L-DOPA treated 6-OHDA-lesioned rats

DOI: 10.1016/j.expneurol.2019.113036

Year: 2019

Effects of adult enriched environment on cognition, hippocampal-prefrontal plasticity and NMDAR subunit expression in MK-801-induced schizophrenia model

DOI: 10.1016/j.euroneuro.2019.03.009

Year: 2019

What Steps Should be Taken if Sample Contamination is Suspected?

What Factors Affect INR Levels?

Can Nipple Creams Prevent Nipple Damage?

What is a DNP?

How to Ensure Proper Ventilation?

What Strategies Can Help Mitigate Assumptions and Biases?

What Role Does Technology Play in Nursing Collaboration?

How Do These Workshops Benefit Nurses?

What were some of the major accomplishments of the NACGN?

What is Minimum Inhibitory Concentration (MIC)?

Partnered Content Networks

Relevant Topics